Hesheng Liu
刘河生
Hesheng Liu is a professor at Harvard Medical School and chief scientist at NeuroXess (优脑银河), a brain-science company he co-founded in 2018 alongside MIT academicians Guoping Feng and Robert Desimone, and entrepreneur Weicheng Wei . His research sits at the intersection of brain and cognitive science, MRI technology, signal processing, and artificial intelligence; he is credited with pioneering the world's first individual-level functional brain mapping technology . Per a 2021 FreeS Capital report, Liu's lab has published over 100 SCI papers, and NeuroXess has pursued clinical trials for conditions including depression, Alzheimer's, Parkinson's, autism, and post-stroke aphasia .
AI-generated — may contain errors, please verify.
Coverage
Every Brain Is a Unique Little Universe | FreeS Fund's World Autism Awareness Day Special
May every life be treated with gentleness.
FreeS Report 24 | Embracing the "Smartest" Opportunity: Investing Boldly in Brain and Neuroscience
If the universe is complex, mysterious, and captivating, so is the brain.
Brain Diseases in Its Crosshairs: NeuroXess Raises $4.2 Million in Angel Round | FreeS Fund Deal News
Brain research remains one of the great unsolved challenges in science.
